Assessment Activities Sample Clauses

Assessment Activities. The Trustees may enter into funding and participation agreements with one or more PRP(s) to fund NRDAR-related activities. Any agreement will address the terms of the monetary disbursement and the level of technical PRP participation. The Trustees acknowledge that payments and/or promises of goods and services for NRDAR-related activities pursuant to any funding and participation agreement, exclusive of the individual costs of their participation, are intended for the joint and undivided use and benefit of all the Trustees acting cooperatively in planning, coordinating and conducting joint Trustee NRDAR-related activities. Prior to the receipt of any such funds, the Trustee Council will, by resolution, determine the appropriate place for the deposit of funds and appropriate activities for the expenditure of these funds recognizing that legal authority may restrict where such funds can be held. Any interest earned on the money deposited in the agreed upon depository shall be credited to the fund and shall be subject to the terms of this MOA. The Trustees will evaluate the most effective means for recovery of their individual costs of participation and seek recovery of these costs through agreement(s) with one or more PRP (s). The Trustees further acknowledge that each Trustee may seek individual reimbursement from any PRP for NRDAR-related activities unanimously approved by the Trustee Council but separately financed by the individual Trustee. However, prior to seeking reimbursement, the Trustee will provide notice and an accounting of the monies sought to the Trustee Council. Additionally, the Trustees will be responsible for maintaining their own accounting for the costs of their participation. The LAT will be responsible for keeping an accounting of any agreed upon joint NRDAR-related activities. It is the goal of the Trustees to minimize administrative costs.
AutoNDA by SimpleDocs
Assessment Activities. WP7 -Evidence gathering and evaluation report This work package is dedicated to pilot evaluation activities. The evaluation of the various trials will be conducted using the MAST (Model for Assessment of Telemedicine) multidimensional evaluation methodology, developed under contract with the European Commission (MethoTelemed project) and based on HTA (Health Technology Assessment). In MAST, evaluation work is seen as a multi-disciplinary process that summarises and evaluates information about the medical, social, economic and ethical issues related to the use of telemedicine in a systematic, unbiased, robust manner. The MAST approach will specifically be tailored to the requirements of the project. Also, the MAST model ensures that the evaluation will cover all services and all stakeholder perspectives.
Assessment Activities. How will we determine if participants a) have reached curriculum objectives identified in number 2 above; and b) can answer the questions in number 3.
Assessment Activities. ‌ The sections below describe the detailed assessment activities, purpose and limitations.
Assessment Activities. Includes all supporting activities other than assessment research, including, but not limited to, assisting sections design their assessment approaches, fulfilling reporting requirements, presenting oral feedback during debriefs, reviewing curricula, etc. Assessment activities may take place at the levels of the individual learner, class/course/curriculum, initiative, program, organization, and enterprise.
Assessment Activities. The Contractor will conduct face-to-face assessments on Company’s members using Contractor’s Assessment tools and Company’s Pilot HRA wherever the member is located when possible. These assessments determine the member’s medical, behavioral health, and social services needs, if any. Contractor will obtain a release of information from the member and then submit completed ILP, Pilot HRA and Transition Care Plan (only for those Care1st members in skilled nursing facilities (SNF’s), rehabilitation hospitals, and acute-care hospitals that wish to transition into the community) and other relevant information (to determine service needs) to via fax or another process, as agreed upon by the parties.
Assessment Activities. To accomplish the objectives of C-1.1, the following will be conducted as set forth in the following table.
AutoNDA by SimpleDocs
Assessment Activities. The assessment activities include at least the following:
Assessment Activities. As part of the assessment pathway, DHHR has decided to use an additional standardized assessment tool, in addition to the CANS. The CAFAS, Child and Adolescent Functional Assessment Scale for children ages 7-20, and the PECFAS, Preschool and Early Childhood Functional Assessment Scale, for youth aged 3–6, will be collected as part of the CSED Waiver eligibility determination. Referrals for the CSED Waiver are made to KEPRO, who will conduct the CAFAS/PECFAS telephonically with families to determine if a child should be further referred to a CSED Waiver independent evaluator. If a child receives a score of 90 or above, KEPRO will assist the family to schedule an appointment with an independent evaluator. If the child scores below 90, KEPRO will assist the family to find other services. Additionally, DHHR has proposed use of the scores from the CAFAS/PECFAS to determine if a child meets the defined class of children under the DOJ Agreement target population definition. Please see the Target Population section on page 7 for additional information regarding target population definition.

Related to Assessment Activities

  • Development Activities The Development activities referred to in item “b” of paragraph 3.1 include: studies and projects of implementation of the Production facilities; drilling and completion of the Producing and injection xxxxx; and installation of equipment and vessels for extraction, collection, Treatment, storage, and transfer of Oil and Gas. The installation referred to in item “c” includes, but is not limited to, offshore platforms, pipelines, Oil and Gas Treatment plants, equipment and facilities for measurement of the inspected Production, wellhead equipment, production pipes, flow lines, tanks, and other facilities exclusively intended for extraction, as well as oil and gas pipelines for Production Outflow and their respective compressor and pumping stations.

  • Independent Activities 14.1 Except as expressly provided herein, each party shall have the free and unrestricted right to independently engage in and receive the full benefit of any and all business endeavours of any sort whatsoever, whether or not competitive with the endeavours contemplated herein without consulting the other or inviting or allowing the other to participate therein. No party shall be under any fiduciary or other duty to the other which will prevent it from engaging in or enjoying the benefits of competing endeavours within the general scope of the endeavours contemplated herein. The legal doctrines of "corporate opportunity" sometimes applied to persons engaged in a joint venture or having fiduciary status shall not apply in the case of any party. In particular, without limiting the foregoing, no party shall have any obligation to any other party as to:

  • PROJECT ACTIVITIES Grantee must perform the project activities set forth on Exhibit A (the “Project”), attached hereto and incorporated in this Grant by this reference, for the period beginning on the Effective Date and ending June 30, 2021 (the “Performance Period”).

  • Development Diligence Novartis shall dedicate commercially reasonable efforts, during each [**] month period, necessary to continue the advancement of Licensed Compounds and Licensed Products with respect to at least one Profile towards the next clinical Development milestone or approval milestone, as described in Sections 7.4.2 or 7.4.3, respectively. If Novartis (itself or through its Affiliates or sublicensees) fails to dedicate commercially reasonable efforts, during any [**] month period, necessary to continue the advancement of Licensed Compounds and Licensed Products with respect to at least one Profile towards such next milestone, then any dispute regarding Novartis’ failure of development diligence with respect to such Profile shall be resolved in accordance with Article 13.

  • Regulatory Activities Beginning on the Effective Date and to the extent UGNX remains the Lead Development Party with respect to a particular territory, subject to and in accordance with the terms and conditions of this Agreement and the requirements of Applicable Laws, UGNX, shall: (a) use Commercially Reasonable Efforts to file (or have filed) all Regulatory Filings with respect to the Licensed Products in the Field in order to obtain Marketing Approvals in each country in the Territory and the European Territory (or to obtain the European Centralized Approval in the European Core Territory) and in order to obtain Pricing and/or Reimbursement Approvals in the Profit Share Territory; (b) respond in a timely fashion to requests for data and information from Regulatory Authorities with respect to the Licensed Products in the Field in the Territory and the European Territory; and (c) meet with officials of the Regulatory Authorities at such times as may be requested by such Regulatory Authorities with respect to the Core Development Activities (“Regulatory Activities”), provided that KHK will have primary responsibility for obtaining, and UGNX shall provide all assistance reasonably requested by KHK, in relation to Pricing and/or Reimbursement Approvals for the Licensed Products in the Field in the European Territory. For the avoidance of doubt, UGNX will be responsible for obtaining, and KHK will provide all assistance reasonably requested by UGNX, in relation to Pricing and/or Reimbursement Approvals, if any, for the Licensed Products in the Field in the Profit Share Territory as part of the UGNX Core Development Activities, it being understood that the costs incurred by UGNX in connection with such activities will be shared equally (50/50). All such Regulatory Activities will be conducted in a manner consistent with the Core Development Plan and coordinated by the JSC in accordance with Article 3. Without limiting the applicability of the foregoing and the remainder of this Article 5, UGNX shall interface with the applicable Regulatory Authority(ies) and, through the JDC, shall keep KHK reasonably informed of all material events and developments occurring in the course of the Regulatory Activities, including scheduled UGNX regulatory strategy discussions and meetings with Regulatory Authorities in the Territory and the European Territory relating to the Licensed Products in the Field.

  • Commercialization Reports Throughout the term of this Agreement and during the Sell-Off Period, and within thirty (30) days of December 31st of each year, Company will deliver to University written reports of Company’s and Sublicensees’ efforts and plans to develop and commercialize the innovations covered by the Licensed Rights and to make and sell Licensed Products. Company will have no obligation to prepare commercialization reports in years where (a) Company delivers to University a written Sales Report with active sales, and (b) Company has fulfilled all Performance Milestones. In relation to each of the Performance Milestones each commercialization report will include sufficient information to demonstrate achievement of those Performance Milestones and will set out timeframes and plans for achieving those Performance Milestones which have not yet been met.

  • Diagnostic Assessment 6.3.1 Boards shall provide a list of pre-approved assessment tools consistent with their Board improvement plan for student achievement and which is compliant with Ministry of Education PPM (PPM 155: Diagnostic Assessment in Support of Student Learning, date of issue January 7, 2013).

  • EXTRA-CURRICULAR ACTIVITIES 1. In this agreement, extra-curricular programs and activities include all those that are beyond the provincially prescribed and locally determined curricula of the school.

  • Activities Except with the prior written consent of the Board, Executive will not during his employment with the Company undertake or engage in any other employment, occupation or business enterprise, other than ones in which Executive is a passive investor. Executive may engage in civic and not-for-profit activities so long as such activities do not materially interfere with the performance of his duties hereunder.

  • Development Work Do, or cause to be done, such development and other work as may be reasonably necessary to protect from diminution and production capacity of the Mortgaged Property and each producing well thereon.

Time is Money Join Law Insider Premium to draft better contracts faster.